These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 31366808)

  • 41. Ceftriaxone--bilirubin-albumin interactions in the neonate: an in vivo study.
    Martin E; Fanconi S; Kälin P; Zwingelstein C; Crevoisier C; Ruch W; Brodersen R
    Eur J Pediatr; 1993 Jun; 152(6):530-4. PubMed ID: 8335024
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pharmacokinetics of ceftriaxone in hemodialysis].
    Laville M; Mercatello A; Freney J; Pozet N; Meugnier H; Labeeuw M; Fleurette J; Zech P
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):719-23. PubMed ID: 3309803
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Determinants of ceftriaxone clearance by continuous venovenous hemofiltration and hemodialysis.
    Matzke GR; Frye RF; Joy MS; Palevsky PM
    Pharmacotherapy; 2000 Jun; 20(6):635-43. PubMed ID: 10853618
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single-dose pharmacokinetics of ceftriaxone in patients with end-stage renal disease and hemodialysis.
    Losno Garcia R; Santivañez V; Battilana CA
    Chemotherapy; 1988; 34(4):261-6. PubMed ID: 3208543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Measurements of IgG and albumin in CSF and serum in various neurological diseases].
    Su CL; Chiu HC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1986 Nov; 19(4):250-7. PubMed ID: 3816368
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Microdialysis and HPLC method for determination of concentration of pantoprazole in rat striatum aftercombined administration with borneol].
    Wei Y; Liu P; He X; Chen Q
    Zhongguo Zhong Yao Za Zhi; 2010 Oct; 35(19):2605-8. PubMed ID: 21174774
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ceftriaxone therapy for asymptomatic neurosyphilis. Case report and Western blot analysis of serum and cerebrospinal fluid IgG response to therapy.
    Hook EW; Baker-Zander SA; Moskovitz BL; Lukehart SA; Handsfield HH
    Sex Transm Dis; 1986; 13(3 Suppl):185-8. PubMed ID: 3764632
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antimicrobial activity of ceftriaxone versus cefotaxime: negative effect of serum albumin binding of ceftriaxone.
    Nath SK; Foster GA; Mandell LA; Rotstein C
    J Antimicrob Chemother; 1994 Jun; 33(6):1239-43. PubMed ID: 7928818
    [No Abstract]   [Full Text] [Related]  

  • 49. [Puncture of ascites: abdominal paracentesis].
    Bosshard S; Müllhaupt B
    Praxis (Bern 1994); 2012 Jun; 101(12):757-64, 766; quiz 765. PubMed ID: 22669777
    [No Abstract]   [Full Text] [Related]  

  • 50. Protein binding characteristics and pharmacokinetics of ceftriaxone in intensive care unit patients.
    Schleibinger M; Steinbach CL; Töpper C; Kratzer A; Liebchen U; Kees F; Salzberger B; Kees MG
    Br J Clin Pharmacol; 2015 Sep; 80(3):525-33. PubMed ID: 25808018
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Human pharmacology of ceftriaxone (author's transl)].
    Le Van Thoi J; Koumare B; Lhoste F; Soussy CJ; Duval J
    Pathol Biol (Paris); 1982 Jun; 30(6):345-7. PubMed ID: 6287386
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The importance of aluminiun in dialyseencephalopathie (author's transl)].
    Ladurner G; Holzer H; Wawschinek O; Pogglitsch H; Petek W
    Fortschr Neurol Psychiatr; 1981 May; 49(5):211-3. PubMed ID: 7239409
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparative analysis of pharmacokinetics of ceftriaxone in serum and pleural fluid in humans: a study of once daily administration by intramuscular and intravenous routes.
    Goonetilleke AK; Dev D; Aziz I; Hughes C; Smith MJ; Basran GS
    J Antimicrob Chemother; 1996 Dec; 38(6):969-76. PubMed ID: 9023644
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics of intravenous and intraperitoneal ceftriaxone in chronic ambulatory peritoneal dialysis.
    Albin H; Ragnaud JM; Demotes-Mainard F; Vinçon G; Couzineau M; Wone C
    Eur J Clin Pharmacol; 1986; 31(4):479-83. PubMed ID: 3816928
    [TBL] [Abstract][Full Text] [Related]  

  • 55. THE PATHOGENESIS AND PREVENTION OF CEREBRAL DYSFUNCTION DURING DIALYSIS.
    KENNEDY AC; LINTON AL; LUKE RG; RENFREW S; DINWOODIE A
    Lancet; 1964 Apr; 1(7337):790-3. PubMed ID: 14108004
    [No Abstract]   [Full Text] [Related]  

  • 56. [Calculation of the IgG fraction of cerebrospinal fluid locally synthesized in the central nervous system (author's transl)].
    Reiber H
    J Clin Chem Clin Biochem; 1979 Sep; 17(9):587-91. PubMed ID: 501305
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exchange of albumin between plasma and cerebrospinal fluid.
    FISHMAN RA
    Am J Physiol; 1953 Oct; 175(1):96-8. PubMed ID: 13114358
    [No Abstract]   [Full Text] [Related]  

  • 58. Comparison of the probability of target attainment between ceftriaxone and cefepime in the cerebrospinal fluid and serum against Streptococcus pneumoniae.
    Lodise TP; Nau R; Kinzig M; Jones RN; Drusano GL; Sörgel F
    Diagn Microbiol Infect Dis; 2007 Aug; 58(4):445-52. PubMed ID: 17512154
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pattern of albumin, immunoglobulins, and glucose in cerebrospinal fluid and serum of patients with disorders of the central nervous system.
    Osenbrück M; Rao ML; Quednau HD
    Eur Neurol; 1985; 24(1):16-22. PubMed ID: 3967672
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ceftriaxone-induced acute reversible encephalopathy in a patient treated for a urinary tract infection.
    Roncon-Albuquerque R; Pires I; Martins R; Real R; Sousa G; von Hafe P
    Neth J Med; 2009 Feb; 67(2):72-5. PubMed ID: 19299850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.